Integrin-αIIbβ3-mediated outside-in signalling activates a negative feedback pathway to suppress platelet activation

Summary

Integrin-αIIbβ3-mediated outside-in signalling is widely accepted as an amplifier of platelet activation; accumulating evidence suggests that outside-in signalling can, under certain conditions, also function as an inhibitor of platelet activation. The role of integrin-αIIbβ3-mediated outside-in signalling in platelet activation is disputable. We employed flow cytometry, aggregometry, immunoprecipitation, and immunoblotting to investigate the role of integrin-αIIbβ3-mediated outside-in signalling in platelet activation. Integrin αIIbβ3 inhibition enhances agonist-induced platelet ATP secretion. Human platelets lacking expression of αIIbβ3 exhibited more platelet ATP secretion than their wild-type counterparts. Moreover, integrin-αIIbβ3-mediated outside-in signals activate SHIP-1, which in turn mediates p-Akt dep-hosphorylation, leading to inactivation of PI3K/Akt signalling. Furthermore, 3AC (SHIP-1 inhibitor) inhibits platelet disaggregation, and promotes platelet ATP secretion. Upon ADP stimulation, Talin is recruited to αIIbβ3, and it is dissociated from αIIbβ3 when platelets disaggregate. In addition, treatment with RUC2, an inhibitor of αIIbβ3, which blocks αIIbβ3-mediated outside-in signalling, can markedly prevent the dissociation of talin from integrin. SHIP1 Inhibitor 3AC inhibits the dissociation of talin from integrin-β3. These results suggest that integrin-αIIbβ3-mediated outside-in signalling can serve as a brake to restrict unnecessary platelet activation by activated SHIP-1, which mediated the disassociation of talin from β3, leading to integrin inactivation and blocking of PI3K/Akt signalling to restrict platelet ATP secretion.

Keywords

Integrins - platelets - ATP - RGD-peptide - talin

^* These authors contributed equally to this work.

• References

• 1 Hynes RO. Integrins: bidirectional, allosteric signalling machines. Cell 2002; 110: 673-687.
• 2 Jackson SP. et al. Phosphoinositide 3-kinases and the regulation of platelet function. Biochem Soc Trans 2004; 32: 387-392.
• 3 Tadokoro S. et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science 2003; 302: 103-106.
• 4 Shattil SJ. et al. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 2010; 11: 288-300.
• 5 Koyasu S. The role of PI3K in immune cells. Nat Immunol 2003; 04: 313-319.
• 6 Di Cristofano A. et al. Pten is essential for embryonic development and tumour suppression. Nat Genet 1998; 19: 348-355.
• 7 Ware MD. et al. Cloning and characterisation of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation. Blood 1996; 88: 2833-2840.
• 8 Millward TA. et al. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999; 24: 186-191.
• 9 Cosemans JM. et al. Multiple ways to switch platelet integrins on and off. J Thromb Haemost 2008; 06: 1253-1261.
• 10 Giles AR. Guidelines for the use of animals in biomedical research. Thromb Haemost 1987; 58: 1078-1084.
• 11 Newman PJ. et al. Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3. Blood 1985; 65: 227-232.
• 12 Morton LF. et al. Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity. Biochem J 1995; 306: 337-344.
• 13 Fang J. et al. Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia. Blood 2005; 106: 2671-2679.
• 14 Brooks R. et al. SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells. J Immunol 2010; 184: 3582-3589.
• 15 Graham GJ. et al. Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo. Blood 2009; 114: 1083-1090.
• 16 Ren Q. et al. The platelet release reaction: just when you thought platelet secretion was simple. Curr Opin Hematol 2008; 15: 537-541.
• 17 Zhang G. et al. Distinct roles for Rap1b protein in platelet secretion and integrin alphaIIbbeta3 outside-in signalling. J Biol Chem 2011; 286: 39466-39477.
• 18 Sandrock-Lang K. et al. Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations. Thromb Haemost 2015; 113: 782-791.
• 19 Wannemacher KM. et al. Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4D. Blood 2010; 116: 5707-5715.
• 20 O’Brien KA. et al. An important role for Akt3 in platelet activation and thrombosis. Blood 2011; 118: 4215-4223.
• 21 Zhang Q, Claret FX. Phosphatases: the new brakes for cancer development?. Enzyme Res 2012; 2012: 659649.
• 22 Araki S. et al. Correlation between albuminuria and spontaneous platelet micro-aggregate formation in type 2 diabetic patients. Diabetes Care 2009; 32: 2062-2067.
• 23 Liu Q. et al. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev 1999; 13: 786-791.
• 24 Severin S. et al. Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth. J Clin Invest 2007; 117: 944-952.
• 25 Woulfe D. et al. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 2004; 113: 441-450.
• 26 Lova P. et al. A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B. J Biol Chem 2003; 278: 131-138.
• 27 Lee HS. et al. RIAM activates integrins by linking talin to ras GTPase membrane-targeting sequences. J Biol Chem 2009; 284: 5119-5127.
• 28 Zhang S. et al. p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells. Biochem Biophys Res Commun 1999; 254: 440-445.
• 29 Salgia R. et al. p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c–Cbl. Exp Hematol 1996; 24: 310-313.
• 30 Tang K. et al. The beta4 integrin subunit rescues A431 cells from apoptosis through a PI3K/Akt kinase signalling pathway. Biochem Biophys Res Commun 1999; 264: 127-132.